However, when whole lysate quantitative mass spectrometry was performed on E-cadherin negative and exogenously amplified E-cadherin in a highly ICB resistant melanoma cell line, there was no difference in the levels of β-catenin. The gene discussed is CDH1; the disease is melanoma.